Pharmaceutical company
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); FDA Globalization Act (H.R. 759); Follow-on Biologics; Comparative Effectiveness: Comparative Effectiveness Research Ace (S. 3408); Enhanced Health Care Value for All Act (H.R. 2184); Promoting Innovation and Access to Life-saving Medicine Act (H.R. 1427/S.726); Biologics Price Competition and Innovation Act (S.1695) General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
BILL K BREWSTER STEVEN E IRIZARRY BILL K BREWSTER STEVEN E IRIZARRY